世界の創傷止血粉末市場予測 2023年-2029年

【英語タイトル】Global Wound Hemostatic Powder Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC07371)・商品コード:LP23DC07371
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の創傷止血粉末市場」は、過去の販売実績から2022年の世界の創傷止血粉末の総販売量を検討し、2023年から2029年の予測される創傷止血粉末の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の創傷止血粉末の市場規模を掲載し、XXX百万米ドル規模の世界の創傷止血粉末市場の詳細な分析を提供します。本インサイトレポートは、世界の創傷止血粉末業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の創傷止血粉末市場における各社の独自のポジションをより深く理解するために、創傷止血粉末製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の創傷止血粉末市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。創傷止血粉末の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。創傷止血粉末の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。創傷止血粉末のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

創傷止血粉末の世界主要メーカーとしては、Pfizer、 BD、 Johnson & Johnson、 MedTrade Products、 C. R. Bard、 Equimedical、 MBP、 Celox、 Ferrosan Medical Devices、 Betatech Medical、 BioCer Entwicklungs、 Hemostasis、 Aegis Lifesciences、 CSL Behring、 Gelita Medicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の創傷止血粉末市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では創傷止血粉末市場をセグメンテーションし、種類別 (植物性止血剤、ゼラチン性止血剤、その他)、用途別 (病院、診療所、外科、家庭、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:植物性止血剤、ゼラチン性止血剤、その他

・用途別区分:病院、診療所、外科、家庭、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の創傷止血粉末市場の10年間の市場状況・展望は?
・世界および地域別に見た創傷止血粉末市場成長の要因は何か?
・創傷止血粉末の市場機会はエンドマーケットの規模によってどのように変化するのか?
・創傷止血粉末のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:創傷止血粉末の年間販売量2018-2029、地域別現状・将来分析
・創傷止血粉末の種類別セグメント:植物性止血剤、ゼラチン性止血剤、その他
・創傷止血粉末の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・創傷止血粉末の用途別セグメント:病院、診療所、外科、家庭、その他
・創傷止血粉末の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の創傷止血粉末市場
・企業別のグローバル創傷止血粉末市場データ:2018-2023年の年間販売量、市場シェア
・企業別の創傷止血粉末の年間売上:2018-2023年の売上、市場シェア
・企業別の創傷止血粉末販売価格
・主要企業の創傷止血粉末生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

創傷止血粉末の地域別レビュー
・地域別の創傷止血粉末市場規模2018-2023:年間販売量、売上
・主要国別の創傷止血粉末市場規模2018-2023:年間販売量、売上
・南北アメリカの創傷止血粉末販売の成長
・アジア太平洋の創傷止血粉末販売の成長
・ヨーロッパの創傷止血粉末販売の成長
・中東・アフリカの創傷止血粉末販売の成長

南北アメリカ市場
・南北アメリカの国別の創傷止血粉末販売量、売上(2018-2023)
・南北アメリカの創傷止血粉末の種類別販売量
・南北アメリカの創傷止血粉末の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の創傷止血粉末販売量、売上(2018-2023)
・アジア太平洋の創傷止血粉末の種類別販売量
・アジア太平洋の創傷止血粉末の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の創傷止血粉末販売量、売上(2018-2023)
・ヨーロッパの創傷止血粉末の種類別販売量
・ヨーロッパの創傷止血粉末の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の創傷止血粉末販売量、売上(2018-2023)
・中東・アフリカの創傷止血粉末の種類別販売量
・中東・アフリカの創傷止血粉末の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・創傷止血粉末の製造コスト構造分析
・創傷止血粉末の製造プロセス分析
・創傷止血粉末の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・創傷止血粉末の主要なグローバル販売業者
・創傷止血粉末の主要なグローバル顧客

地域別の創傷止血粉末市場予測レビュー
・地域別の創傷止血粉末市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・創傷止血粉末の種類別市場規模予測
・創傷止血粉末の用途別市場規模予測

主要企業分析
Pfizer、 BD、 Johnson & Johnson、 MedTrade Products、 C. R. Bard、 Equimedical、 MBP、 Celox、 Ferrosan Medical Devices、 Betatech Medical、 BioCer Entwicklungs、 Hemostasis、 Aegis Lifesciences、 CSL Behring、 Gelita Medical
・企業情報
・創傷止血粉末製品
・創傷止血粉末販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Wound Hemostatic Powder market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Wound Hemostatic Powder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wound Hemostatic Powder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wound Hemostatic Powder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wound Hemostatic Powder players cover Pfizer, BD, Johnson & Johnson, MedTrade Products, C. R. Bard, Equimedical, MBP, Celox and Ferrosan Medical Devices, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Wound Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Wound Hemostatic Powder sales in 2022, providing a comprehensive analysis by region and market sector of projected Wound Hemostatic Powder sales for 2023 through 2029. With Wound Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wound Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Wound Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wound Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Wound Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wound Hemostatic Powder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wound Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Wound Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Plant Hemostatic Powder
Gelatin Hemostatic Powder
Others
Segmentation by application
Hospital
Clinic
Surgery Center
Household
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
BD
Johnson & Johnson
MedTrade Products
C. R. Bard
Equimedical
MBP
Celox
Ferrosan Medical Devices
Betatech Medical
BioCer Entwicklungs
Hemostasis
Aegis Lifesciences
CSL Behring
Gelita Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wound Hemostatic Powder market?
What factors are driving Wound Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wound Hemostatic Powder market opportunities vary by end market size?
How does Wound Hemostatic Powder break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wound Hemostatic Powder Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wound Hemostatic Powder by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wound Hemostatic Powder by Country/Region, 2018, 2022 & 2029
2.2 Wound Hemostatic Powder Segment by Type
2.2.1 Plant Hemostatic Powder
2.2.2 Gelatin Hemostatic Powder
2.2.3 Others
2.3 Wound Hemostatic Powder Sales by Type
2.3.1 Global Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
2.3.2 Global Wound Hemostatic Powder Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wound Hemostatic Powder Sale Price by Type (2018-2023)
2.4 Wound Hemostatic Powder Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Surgery Center
2.4.4 Household
2.4.5 Others
2.5 Wound Hemostatic Powder Sales by Application
2.5.1 Global Wound Hemostatic Powder Sale Market Share by Application (2018-2023)
2.5.2 Global Wound Hemostatic Powder Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wound Hemostatic Powder Sale Price by Application (2018-2023)
3 Global Wound Hemostatic Powder by Company
3.1 Global Wound Hemostatic Powder Breakdown Data by Company
3.1.1 Global Wound Hemostatic Powder Annual Sales by Company (2018-2023)
3.1.2 Global Wound Hemostatic Powder Sales Market Share by Company (2018-2023)
3.2 Global Wound Hemostatic Powder Annual Revenue by Company (2018-2023)
3.2.1 Global Wound Hemostatic Powder Revenue by Company (2018-2023)
3.2.2 Global Wound Hemostatic Powder Revenue Market Share by Company (2018-2023)
3.3 Global Wound Hemostatic Powder Sale Price by Company
3.4 Key Manufacturers Wound Hemostatic Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wound Hemostatic Powder Product Location Distribution
3.4.2 Players Wound Hemostatic Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wound Hemostatic Powder by Geographic Region
4.1 World Historic Wound Hemostatic Powder Market Size by Geographic Region (2018-2023)
4.1.1 Global Wound Hemostatic Powder Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wound Hemostatic Powder Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wound Hemostatic Powder Market Size by Country/Region (2018-2023)
4.2.1 Global Wound Hemostatic Powder Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wound Hemostatic Powder Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wound Hemostatic Powder Sales Growth
4.4 APAC Wound Hemostatic Powder Sales Growth
4.5 Europe Wound Hemostatic Powder Sales Growth
4.6 Middle East & Africa Wound Hemostatic Powder Sales Growth
5 Americas
5.1 Americas Wound Hemostatic Powder Sales by Country
5.1.1 Americas Wound Hemostatic Powder Sales by Country (2018-2023)
5.1.2 Americas Wound Hemostatic Powder Revenue by Country (2018-2023)
5.2 Americas Wound Hemostatic Powder Sales by Type
5.3 Americas Wound Hemostatic Powder Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wound Hemostatic Powder Sales by Region
6.1.1 APAC Wound Hemostatic Powder Sales by Region (2018-2023)
6.1.2 APAC Wound Hemostatic Powder Revenue by Region (2018-2023)
6.2 APAC Wound Hemostatic Powder Sales by Type
6.3 APAC Wound Hemostatic Powder Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wound Hemostatic Powder by Country
7.1.1 Europe Wound Hemostatic Powder Sales by Country (2018-2023)
7.1.2 Europe Wound Hemostatic Powder Revenue by Country (2018-2023)
7.2 Europe Wound Hemostatic Powder Sales by Type
7.3 Europe Wound Hemostatic Powder Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wound Hemostatic Powder by Country
8.1.1 Middle East & Africa Wound Hemostatic Powder Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wound Hemostatic Powder Revenue by Country (2018-2023)
8.2 Middle East & Africa Wound Hemostatic Powder Sales by Type
8.3 Middle East & Africa Wound Hemostatic Powder Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wound Hemostatic Powder
10.3 Manufacturing Process Analysis of Wound Hemostatic Powder
10.4 Industry Chain Structure of Wound Hemostatic Powder
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wound Hemostatic Powder Distributors
11.3 Wound Hemostatic Powder Customer
12 World Forecast Review for Wound Hemostatic Powder by Geographic Region
12.1 Global Wound Hemostatic Powder Market Size Forecast by Region
12.1.1 Global Wound Hemostatic Powder Forecast by Region (2024-2029)
12.1.2 Global Wound Hemostatic Powder Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wound Hemostatic Powder Forecast by Type
12.7 Global Wound Hemostatic Powder Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Wound Hemostatic Powder Product Portfolios and Specifications
13.1.3 Pfizer Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Wound Hemostatic Powder Product Portfolios and Specifications
13.2.3 BD Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Wound Hemostatic Powder Product Portfolios and Specifications
13.3.3 Johnson & Johnson Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 MedTrade Products
13.4.1 MedTrade Products Company Information
13.4.2 MedTrade Products Wound Hemostatic Powder Product Portfolios and Specifications
13.4.3 MedTrade Products Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MedTrade Products Main Business Overview
13.4.5 MedTrade Products Latest Developments
13.5 C. R. Bard
13.5.1 C. R. Bard Company Information
13.5.2 C. R. Bard Wound Hemostatic Powder Product Portfolios and Specifications
13.5.3 C. R. Bard Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 C. R. Bard Main Business Overview
13.5.5 C. R. Bard Latest Developments
13.6 Equimedical
13.6.1 Equimedical Company Information
13.6.2 Equimedical Wound Hemostatic Powder Product Portfolios and Specifications
13.6.3 Equimedical Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Equimedical Main Business Overview
13.6.5 Equimedical Latest Developments
13.7 MBP
13.7.1 MBP Company Information
13.7.2 MBP Wound Hemostatic Powder Product Portfolios and Specifications
13.7.3 MBP Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MBP Main Business Overview
13.7.5 MBP Latest Developments
13.8 Celox
13.8.1 Celox Company Information
13.8.2 Celox Wound Hemostatic Powder Product Portfolios and Specifications
13.8.3 Celox Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Celox Main Business Overview
13.8.5 Celox Latest Developments
13.9 Ferrosan Medical Devices
13.9.1 Ferrosan Medical Devices Company Information
13.9.2 Ferrosan Medical Devices Wound Hemostatic Powder Product Portfolios and Specifications
13.9.3 Ferrosan Medical Devices Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ferrosan Medical Devices Main Business Overview
13.9.5 Ferrosan Medical Devices Latest Developments
13.10 Betatech Medical
13.10.1 Betatech Medical Company Information
13.10.2 Betatech Medical Wound Hemostatic Powder Product Portfolios and Specifications
13.10.3 Betatech Medical Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Betatech Medical Main Business Overview
13.10.5 Betatech Medical Latest Developments
13.11 BioCer Entwicklungs
13.11.1 BioCer Entwicklungs Company Information
13.11.2 BioCer Entwicklungs Wound Hemostatic Powder Product Portfolios and Specifications
13.11.3 BioCer Entwicklungs Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 BioCer Entwicklungs Main Business Overview
13.11.5 BioCer Entwicklungs Latest Developments
13.12 Hemostasis
13.12.1 Hemostasis Company Information
13.12.2 Hemostasis Wound Hemostatic Powder Product Portfolios and Specifications
13.12.3 Hemostasis Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hemostasis Main Business Overview
13.12.5 Hemostasis Latest Developments
13.13 Aegis Lifesciences
13.13.1 Aegis Lifesciences Company Information
13.13.2 Aegis Lifesciences Wound Hemostatic Powder Product Portfolios and Specifications
13.13.3 Aegis Lifesciences Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aegis Lifesciences Main Business Overview
13.13.5 Aegis Lifesciences Latest Developments
13.14 CSL Behring
13.14.1 CSL Behring Company Information
13.14.2 CSL Behring Wound Hemostatic Powder Product Portfolios and Specifications
13.14.3 CSL Behring Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CSL Behring Main Business Overview
13.14.5 CSL Behring Latest Developments
13.15 Gelita Medical
13.15.1 Gelita Medical Company Information
13.15.2 Gelita Medical Wound Hemostatic Powder Product Portfolios and Specifications
13.15.3 Gelita Medical Wound Hemostatic Powder Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Gelita Medical Main Business Overview
13.15.5 Gelita Medical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Wound Hemostatic Powder Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Wound Hemostatic Powder Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Plant Hemostatic Powder
Table 4. Major Players of Gelatin Hemostatic Powder
Table 5. Major Players of Others
Table 6. Global Wound Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 7. Global Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
Table 8. Global Wound Hemostatic Powder Revenue by Type (2018-2023) & ($ million)
Table 9. Global Wound Hemostatic Powder Revenue Market Share by Type (2018-2023)
Table 10. Global Wound Hemostatic Powder Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Wound Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 12. Global Wound Hemostatic Powder Sales Market Share by Application (2018-2023)
Table 13. Global Wound Hemostatic Powder Revenue by Application (2018-2023)
Table 14. Global Wound Hemostatic Powder Revenue Market Share by Application (2018-2023)
Table 15. Global Wound Hemostatic Powder Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Wound Hemostatic Powder Sales by Company (2018-2023) & (K Units)
Table 17. Global Wound Hemostatic Powder Sales Market Share by Company (2018-2023)
Table 18. Global Wound Hemostatic Powder Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Wound Hemostatic Powder Revenue Market Share by Company (2018-2023)
Table 20. Global Wound Hemostatic Powder Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Wound Hemostatic Powder Producing Area Distribution and Sales Area
Table 22. Players Wound Hemostatic Powder Products Offered
Table 23. Wound Hemostatic Powder Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Wound Hemostatic Powder Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Wound Hemostatic Powder Sales Market Share Geographic Region (2018-2023)
Table 28. Global Wound Hemostatic Powder Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Wound Hemostatic Powder Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Wound Hemostatic Powder Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Wound Hemostatic Powder Sales Market Share by Country/Region (2018-2023)
Table 32. Global Wound Hemostatic Powder Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Wound Hemostatic Powder Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Wound Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 35. Americas Wound Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 36. Americas Wound Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Wound Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 38. Americas Wound Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 39. Americas Wound Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 40. APAC Wound Hemostatic Powder Sales by Region (2018-2023) & (K Units)
Table 41. APAC Wound Hemostatic Powder Sales Market Share by Region (2018-2023)
Table 42. APAC Wound Hemostatic Powder Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Wound Hemostatic Powder Revenue Market Share by Region (2018-2023)
Table 44. APAC Wound Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 45. APAC Wound Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 46. Europe Wound Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 47. Europe Wound Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 48. Europe Wound Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Wound Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 50. Europe Wound Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 51. Europe Wound Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Wound Hemostatic Powder Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Wound Hemostatic Powder Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Wound Hemostatic Powder Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Wound Hemostatic Powder Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Wound Hemostatic Powder Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Wound Hemostatic Powder Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Wound Hemostatic Powder
Table 59. Key Market Challenges & Risks of Wound Hemostatic Powder
Table 60. Key Industry Trends of Wound Hemostatic Powder
Table 61. Wound Hemostatic Powder Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Wound Hemostatic Powder Distributors List
Table 64. Wound Hemostatic Powder Customer List
Table 65. Global Wound Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Wound Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Wound Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Wound Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Wound Hemostatic Powder Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Wound Hemostatic Powder Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Wound Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Wound Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Wound Hemostatic Powder Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Wound Hemostatic Powder Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Wound Hemostatic Powder Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Wound Hemostatic Powder Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Wound Hemostatic Powder Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Wound Hemostatic Powder Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Wound Hemostatic Powder Product Portfolios and Specifications
Table 81. Pfizer Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. BD Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 85. BD Wound Hemostatic Powder Product Portfolios and Specifications
Table 86. BD Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. BD Main Business
Table 88. BD Latest Developments
Table 89. Johnson & Johnson Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Wound Hemostatic Powder Product Portfolios and Specifications
Table 91. Johnson & Johnson Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. MedTrade Products Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 95. MedTrade Products Wound Hemostatic Powder Product Portfolios and Specifications
Table 96. MedTrade Products Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. MedTrade Products Main Business
Table 98. MedTrade Products Latest Developments
Table 99. C. R. Bard Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 100. C. R. Bard Wound Hemostatic Powder Product Portfolios and Specifications
Table 101. C. R. Bard Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. C. R. Bard Main Business
Table 103. C. R. Bard Latest Developments
Table 104. Equimedical Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 105. Equimedical Wound Hemostatic Powder Product Portfolios and Specifications
Table 106. Equimedical Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Equimedical Main Business
Table 108. Equimedical Latest Developments
Table 109. MBP Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 110. MBP Wound Hemostatic Powder Product Portfolios and Specifications
Table 111. MBP Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. MBP Main Business
Table 113. MBP Latest Developments
Table 114. Celox Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 115. Celox Wound Hemostatic Powder Product Portfolios and Specifications
Table 116. Celox Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Celox Main Business
Table 118. Celox Latest Developments
Table 119. Ferrosan Medical Devices Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 120. Ferrosan Medical Devices Wound Hemostatic Powder Product Portfolios and Specifications
Table 121. Ferrosan Medical Devices Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Ferrosan Medical Devices Main Business
Table 123. Ferrosan Medical Devices Latest Developments
Table 124. Betatech Medical Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 125. Betatech Medical Wound Hemostatic Powder Product Portfolios and Specifications
Table 126. Betatech Medical Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Betatech Medical Main Business
Table 128. Betatech Medical Latest Developments
Table 129. BioCer Entwicklungs Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 130. BioCer Entwicklungs Wound Hemostatic Powder Product Portfolios and Specifications
Table 131. BioCer Entwicklungs Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. BioCer Entwicklungs Main Business
Table 133. BioCer Entwicklungs Latest Developments
Table 134. Hemostasis Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 135. Hemostasis Wound Hemostatic Powder Product Portfolios and Specifications
Table 136. Hemostasis Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Hemostasis Main Business
Table 138. Hemostasis Latest Developments
Table 139. Aegis Lifesciences Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 140. Aegis Lifesciences Wound Hemostatic Powder Product Portfolios and Specifications
Table 141. Aegis Lifesciences Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Aegis Lifesciences Main Business
Table 143. Aegis Lifesciences Latest Developments
Table 144. CSL Behring Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 145. CSL Behring Wound Hemostatic Powder Product Portfolios and Specifications
Table 146. CSL Behring Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. CSL Behring Main Business
Table 148. CSL Behring Latest Developments
Table 149. Gelita Medical Basic Information, Wound Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 150. Gelita Medical Wound Hemostatic Powder Product Portfolios and Specifications
Table 151. Gelita Medical Wound Hemostatic Powder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Gelita Medical Main Business
Table 153. Gelita Medical Latest Developments
List of Figures
Figure 1. Picture of Wound Hemostatic Powder
Figure 2. Wound Hemostatic Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Wound Hemostatic Powder Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Wound Hemostatic Powder Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Wound Hemostatic Powder Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Plant Hemostatic Powder
Figure 10. Product Picture of Gelatin Hemostatic Powder
Figure 11. Product Picture of Others
Figure 12. Global Wound Hemostatic Powder Sales Market Share by Type in 2022
Figure 13. Global Wound Hemostatic Powder Revenue Market Share by Type (2018-2023)
Figure 14. Wound Hemostatic Powder Consumed in Hospital
Figure 15. Global Wound Hemostatic Powder Market: Hospital (2018-2023) & (K Units)
Figure 16. Wound Hemostatic Powder Consumed in Clinic
Figure 17. Global Wound Hemostatic Powder Market: Clinic (2018-2023) & (K Units)
Figure 18. Wound Hemostatic Powder Consumed in Surgery Center
Figure 19. Global Wound Hemostatic Powder Market: Surgery Center (2018-2023) & (K Units)
Figure 20. Wound Hemostatic Powder Consumed in Household
Figure 21. Global Wound Hemostatic Powder Market: Household (2018-2023) & (K Units)
Figure 22. Wound Hemostatic Powder Consumed in Others
Figure 23. Global Wound Hemostatic Powder Market: Others (2018-2023) & (K Units)
Figure 24. Global Wound Hemostatic Powder Sales Market Share by Application (2022)
Figure 25. Global Wound Hemostatic Powder Revenue Market Share by Application in 2022
Figure 26. Wound Hemostatic Powder Sales Market by Company in 2022 (K Units)
Figure 27. Global Wound Hemostatic Powder Sales Market Share by Company in 2022
Figure 28. Wound Hemostatic Powder Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Wound Hemostatic Powder Revenue Market Share by Company in 2022
Figure 30. Global Wound Hemostatic Powder Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Wound Hemostatic Powder Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Wound Hemostatic Powder Sales 2018-2023 (K Units)
Figure 33. Americas Wound Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 34. APAC Wound Hemostatic Powder Sales 2018-2023 (K Units)
Figure 35. APAC Wound Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 36. Europe Wound Hemostatic Powder Sales 2018-2023 (K Units)
Figure 37. Europe Wound Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Wound Hemostatic Powder Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Wound Hemostatic Powder Revenue 2018-2023 ($ Millions)
Figure 40. Americas Wound Hemostatic Powder Sales Market Share by Country in 2022
Figure 41. Americas Wound Hemostatic Powder Revenue Market Share by Country in 2022
Figure 42. Americas Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 43. Americas Wound Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 44. United States Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Wound Hemostatic Powder Sales Market Share by Region in 2022
Figure 49. APAC Wound Hemostatic Powder Revenue Market Share by Regions in 2022
Figure 50. APAC Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 51. APAC Wound Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 52. China Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Wound Hemostatic Powder Sales Market Share by Country in 2022
Figure 60. Europe Wound Hemostatic Powder Revenue Market Share by Country in 2022
Figure 61. Europe Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 62. Europe Wound Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 63. Germany Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Wound Hemostatic Powder Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Wound Hemostatic Powder Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Wound Hemostatic Powder Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Wound Hemostatic Powder Sales Market Share by Application (2018-2023)
Figure 72. Egypt Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Wound Hemostatic Powder Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Wound Hemostatic Powder in 2022
Figure 78. Manufacturing Process Analysis of Wound Hemostatic Powder
Figure 79. Industry Chain Structure of Wound Hemostatic Powder
Figure 80. Channels of Distribution
Figure 81. Global Wound Hemostatic Powder Sales Market Forecast by Region (2024-2029)
Figure 82. Global Wound Hemostatic Powder Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Wound Hemostatic Powder Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Wound Hemostatic Powder Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Wound Hemostatic Powder Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Wound Hemostatic Powder Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の創傷止血粉末市場予測 2023年-2029年] (コード:LP23DC07371)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の創傷止血粉末市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆